The Wall Street Journal investigative reporter whose new book chronicles the spectacular collapse of the blood-testing company Theranos and its alleged fraudulent activity told a Harvard audience that the fall is a cautionary tale for other high-tech firms aspiring to disrupt the health care industry.
During the introduction to the book launch event for “Big Data, Health Law, and Bioethics,” one of the editors, Harvard Law School Professor I. Glenn Cohen ’03, faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, told a story about how powerful – and perhaps foreboding – big data can be.
On Jan. 23, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen launched a new collaboration, the Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL).
This fall, the Harvard Law School Library hosted a series of book talks by HLS authors, with topics ranging from Justice and Leadership in Early Islamic Courts to a Citizen’s Guide to Impeachment. As part of this ongoing series, faculty authors from various disciplines shared their research and discussed their recently published books.